Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Feb;24(1):27-67.
doi: 10.1177/0962280214537344. Epub 2014 Jun 11.

Quantitative imaging biomarkers: a review of statistical methods for technical performance assessment

Affiliations
Review

Quantitative imaging biomarkers: a review of statistical methods for technical performance assessment

David L Raunig et al. Stat Methods Med Res. 2015 Feb.

Abstract

Technological developments and greater rigor in the quantitative measurement of biological features in medical images have given rise to an increased interest in using quantitative imaging biomarkers to measure changes in these features. Critical to the performance of a quantitative imaging biomarker in preclinical or clinical settings are three primary metrology areas of interest: measurement linearity and bias, repeatability, and the ability to consistently reproduce equivalent results when conditions change, as would be expected in any clinical trial. Unfortunately, performance studies to date differ greatly in designs, analysis method, and metrics used to assess a quantitative imaging biomarker for clinical use. It is therefore difficult or not possible to integrate results from different studies or to use reported results to design studies. The Radiological Society of North America and the Quantitative Imaging Biomarker Alliance with technical, radiological, and statistical experts developed a set of technical performance analysis methods, metrics, and study designs that provide terminology, metrics, and methods consistent with widely accepted metrological standards. This document provides a consistent framework for the conduct and evaluation of quantitative imaging biomarker performance studies so that results from multiple studies can be compared, contrasted, or combined.

Keywords: agreement; bias; imaging biomarkers; linearity; precision; quantitative imaging; reliability; repeatability; reproducibility.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The Quantitative Image Biomarker analytical process.
Figure 2
Figure 2
Plot of Phantom Volumes versus Measured volumes with identity line (dashed black). Values were taken from QIBA 3A data on phantom volumes and augmented with simulated data for illustration purposes.
Figure 3
Figure 3
Measuring interval analysis of bias. Note that the values measured beyond the measuring interval are necessary to define the interval.
Figure 4
Figure 4
Bias plotted against Truth for the relationship Y=1.4*X+ε with σ2=1.0
Figure 5
Figure 5
QIB measurement variability plots for comparison to the reference values
Figure 6
Figure 6
Linearity Example derived from the QIBA 3A challenge
Figure 7
Figure 7
Bland-Altman-like plot example of agreement when a reference is available
Figure 8
Figure 8
Bland-Altman-like plot for analysis of repeatability using QIBA publicly available data when reference values are not available (see 11.1.1 for data). All original volumes are in mm3.
Figure 9
Figure 9
Relationship of sample size to rSEVw for k= 2,3,4. rSEVw values as a function of the total number of N measurements are also shown for N= 32, 48, 60, 120.
Figure 10
Figure 10
Phantom CT volumetry comparison of two methods plotted for logtransformed data (original units- mm3). Figure (a) slope=0.974, intercept= 0.086. Figure (b) shows the Bland-Altman plot with Lower and Upper agreement limits. Correlation = 0.99; RDC=0.234
Figure 11
Figure 11
Box-Whisker Plot for multigroup reproducibility. Points are jittered for viewing. Whiskers indicate 1.5*IQR outlier boundary

References

    1. Mueller DK, Kutscherenko A, Bartel H, Vlassenbroek A, Ourednicek P, Erckenbrecht J. Phantom-less QCT BMD system as screening tool for osteoporosis without additional radiation. European journal of radiology. 2011;79:375–81. - PubMed
    1. Habte F, Budhiraja S, Keren S, Doyle TC, Levin CS, Paik DS. In situ study of the impact of inter-and intra-reader variability on region of interest (ROI) analysis in preclinical molecular imaging. American journal of nuclear medicine and molecular imaging. 2013;3:175. - PMC - PubMed
    1. Bhavane R, Badea C, Ghaghada KB, et al. Dual-Energy Computed Tomography Imaging of Atherosclerotic Plaques in a Mouse Model Using a Liposomal-Iodine Nanoparticle Contrast Agent. Circulation: Cardiovascular Imaging. 2013;6:285–94. - PMC - PubMed
    1. Hamburg MA, Collins FS. The path to personalized medicine. The New England journal of medicine. 2010;363:301–4. - PubMed
    1. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clinical pharmacology and therapeutics. 2001;69:89–95. - PubMed

Publication types